Detalhe da pesquisa
1.
Immune Response to Dengue and Zika.
Annu Rev Immunol
; 36: 279-308, 2018 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29345964
2.
Flaviviruses hijack the host microbiota to facilitate their transmission.
Cell
; 185(14): 2395-2397, 2022 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35803242
3.
How a broadly neutralizing antibody grapples with antigenic and conformational diversity in dengue virus.
Cell
; 184(25): 6015-6016, 2021 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34856127
4.
Human antibody C10 neutralizes by diminishing Zika but enhancing dengue virus dynamics.
Cell
; 184(25): 6067-6080.e13, 2021 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34852238
5.
The epitope arrangement on flavivirus particles contributes to Mab C10's extraordinary neutralization breadth across Zika and dengue viruses.
Cell
; 184(25): 6052-6066.e18, 2021 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34852239
6.
Global and cell type-specific immunological hallmarks of severe dengue progression identified via a systems immunology approach.
Nat Immunol
; 24(12): 2150-2163, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37872316
7.
Protective Zika vaccines engineered to eliminate enhancement of dengue infection via immunodominance switch.
Nat Immunol
; 22(8): 958-968, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34267374
8.
Immune response to dengue virus and prospects for a vaccine.
Annu Rev Immunol
; 29: 587-619, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21219187
9.
Comparative Flavivirus-Host Protein Interaction Mapping Reveals Mechanisms of Dengue and Zika Virus Pathogenesis.
Cell
; 175(7): 1931-1945.e18, 2018 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30550790
10.
What Came First-the Virus or the Egg?
Cell
; 168(5): 755-757, 2017 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28235193
11.
A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection.
Nat Immunol
; 20(10): 1291-1298, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31477918
13.
Rapid, Low-Cost Detection of Zika Virus Using Programmable Biomolecular Components.
Cell
; 165(5): 1255-1266, 2016 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27160350
14.
Severe dengue progression beyond enhancement.
Nat Immunol
; 24(12): 1967-1969, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38012410
15.
Molecular Insight into Dengue Virus Pathogenesis and Its Implications for Disease Control.
Cell
; 162(3): 488-92, 2015 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26232221
16.
Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope.
Cell
; 162(3): 493-504, 2015 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26189681
17.
Defining Hsp70 Subnetworks in Dengue Virus Replication Reveals Key Vulnerability in Flavivirus Infection.
Cell
; 163(5): 1108-1123, 2015 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26582131
18.
Germline bias dictates cross-serotype reactivity in a common dengue-virus-specific CD8+ T cell response.
Nat Immunol
; 18(11): 1228-1237, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28945243
19.
Blocking NS3-NS4B interaction inhibits dengue virus in non-human primates.
Nature
; 615(7953): 678-686, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36922586
20.
Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus.
Nat Immunol
; 17(9): 1102-8, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27339099